Therapeutic targeting of the mitochondrial dysfunction-PANoptosis axis: Mechanistic insights and emerging strategies
Translational Research · 2026-05 · 291 · 1-39
DOI: 10.1016/j.trsl.2026.03.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Research, 2026-05. Verfasst von Arpit Sharma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biomolecular Engineering Laboratory, School of Biochemical Engineering, Indian Institute of Technology (IIT-BHU), Varanasi, Uttar Pradesh 221005, Ind…. Hauptthemen laut MEDLINE: Mitochondria, Necroptosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 420 Literaturangaben. Gefördert von: Banaras Hindu University, Institute of Biomedical Science, Ministry of Education, India.
Abstract (Originalsprache)
Mitochondria are fundamental organelles that regulate cellular homeostasis through energy production, metabolic integration, and signaling cascades. Beyond their bioenergetic role, mitochondrial dysfunction is increasingly recognized as a pivotal instigator of PANoptosis, a novel, coordinated inflammatory cell death pathway that amalgamates key features of pyroptosis, apoptosis, and necroptosis. This integrated cell death is executed by multiprotein complexes termed PANoptosomes, which are nucleated by specific sensors like ZBP1, AIM2, and NLRC5. Central to this process is the release of mitochondrial danger signals, including reactive oxygen species (ROS) and mitochondrial DNA (mtDNA), which act as potent upstream triggers. For instance, ROS can directly oxidize and activate necroptotic mediators like RIPK1, while cytosolic mtDNA engages innate immune sensors such as cGAS-STING and inflammasomes, thereby initiating PANoptosome assembly. Concurrently, defects in core mitochondrial processes including impaired oxidative phosphorylation, disrupted dynamics (fission/fusion), and faulty mitophagy exacerbate these inflammatory signals, creating a permissive environment for PANoptosis. This mitochondrial-PANoptosis axis is implicated in the pathogenesis of a broad spectrum of diseases. Consequently, therapeutic strategies targeting mitochondrial integrity or specific PANoptotic components hold significant promise for mitigating pathological inflammation and cell loss. This review focuses on the molecular mechanisms linking mitochondrial dysfunction to PANoptosis and explores the translational potential of this interplay to reshape therapeutic approaches in diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomolecular Engineering Laboratory, School of Biochemical Engineering, Indian Institute of Technology (IIT-BHU), Varanasi, Uttar Pradesh 221005, India; Translational Cancer research and Immunology Lab, Department of Ph…
- Biomolecular Engineering Laboratory, School of Biochemical Engineering, Indian Institute of Technology (IIT-BHU), Varanasi, Uttar Pradesh 221005, India.
- Translational Cancer research and Immunology Lab, Department of Pharmacology, Institute of Medical Science-Banaras Hindu University, Varanasi, Uttar Pradesh 221005, India; Department of Pharmacology, Baba kinaram state…
- Biomolecular Engineering Laboratory, School of Biochemical Engineering, Indian Institute of Technology (IIT-BHU), Varanasi, Uttar Pradesh 221005, India. Electronic address: abham.bce@itbhu.ac.in.
Förderung
- Banaras Hindu University
- Institute of Biomedical Science
- Ministry of Education, India
- Life Sciences Research Board
- Defence Research and Development Organisation
Zitieren
APA
Sharma, A., Raut, S. S., Shukla, A., Singh, A., & Mishra, A. (2026). Therapeutic targeting of the mitochondrial dysfunction-PANoptosis axis: Mechanistic insights and emerging strategies. Translational Research, 291, 1-39. https://doi.org/10.1016/j.trsl.2026.03.004
Vancouver
Sharma A, Raut SS, Shukla A, Singh A, Mishra A. Therapeutic targeting of the mitochondrial dysfunction-PANoptosis axis: Mechanistic insights and emerging strategies. Translational Research. 2026;291:1-39. doi:10.1016/j.trsl.2026.03.004
BibTeX
@article{Sharma2026,
author = {Sharma, Arpit and Raut, Shruti S and Shukla, Alok and Singh, Amit and Mishra, Abha},
title = {Therapeutic targeting of the mitochondrial dysfunction-PANoptosis axis: Mechanistic insights and emerging strategies},
journal = {Translational Research},
year = {2026},
volume = {291},
pages = {1--39},
doi = {10.1016/j.trsl.2026.03.004}
}
EUVIMED